Author profile
Editorial team for Peptide Therapy Guide.
From this author
Two studies have found that babies who put on weight too fast in their first months are more likely to become fat as adults. The studies showed that at 5–8 years old, children who were given the enriched formu…
Read guide →Gestational diabetes can cause a multitude of complications in the offspring, but to date, the reasons are incompletely understood. A new study, exploring a foundational step in the process of building protein…
Read guide →In a study led by researchers at Mass General Brigham, pregnant individuals who stopped taking popular weight loss GLP-1 medications before or early in their pregnancy tended to gain more weight and have highe…
Read guide →In people with primary progressive multiple sclerosis (MS), a new study has found no difference in the amount of time before disability worsened between people taking certain medications and those not receivin…
Read guide →New research shows that women who halt GLP-1 medications near conception face greater gestational weight gain and elevated risks for preterm birth and pregnancy-related complications, raising urgent questions …
Read guide →New research shows that certain flavonols from everyday foods can shut down the body’s drug-resistance machinery, potentially paving the way for more effective treatments, but clinical hurdles remain. Study: I…
Read guide →After losing and regaining the same 20-plus pounds more times than she could count, Anita Blanchard concluded that diets don't work. So when the University of North Carolina-Charlotte professor learned that Oz…
Read guide →University of Virginia School of Medicine scientists have developed a bold new approach to drug development and discovery that could dramatically accelerate the creation of new medicines. UVA's Nikolay V. Dokh…
Read guide →After combing through 4,000 existing medications, an artificial intelligence tool helped uncover one that saved the life of a patient with idiopathic multicentric Castleman's disease (iMCD). This rare disease …
Read guide →Scientists have made a key breakthrough for treating respiratory diseases by developing a new drug delivery system that transports genetic therapies directly to the lungs, opening promising possibilities for p…
Read guide →Australian researchers have developed a powerful new way to target deadly, drug-resistant bacteria by designing antibodies that recognize a sugar found only on bacterial cells – an advance that could underpin …
Read guide →A preclinical study from scientists at Scripps Research finds that a drug already FDA-approved for treating inflammatory conditions may help reduce both alcohol intake and pain sensitivity-two issues that comm…
Read guide →In a move to strengthen its presence in the regenerative field, Fujifilm Holdings said it plans to acquire Cellular Dynamics International (CDI) for $16.5 per share or about $307 million. Once the transaction …
Read guide →Sun Pharmaceutical Industries, through its subsidiary, and Intrexon have formed a joint venture to develop controllable gene-based therapies for the treatment of ocular diseases that cause partial or total bli…
Read guide →A center that will identify new drug targets based on protein research at University of Massachusetts (UMass) Amherst is among western Massachusetts projects winning a total $100.5 million in funding from the …
Read guide →PDL BioPharma has acquired exclusive worldwide rights to two antihypertension drugs from Novartis through an investment in a new majority-owned subsidiary. PDL said yesterday it will invest up to $294 million …
Read guide →Peptide therapeutics developer Rhythm Pharmaceuticals said today its subsidiary won a $1 million research grant from the FDA Office of Orphan Products Development toward an ongoing Phase II study of its MC4 ag…
Read guide →It's long been known that tau is a key brain protein involved in Alzheimer's disease and other brain diseases. Aggregates of tau, known as neurofibrillary tangles, have been associated with nerve cell death an…
Read guide →Teva Pharmaceutical Industries has ended a 2.5-year, up-to-$410 million-plus collaboration with Sosei Group’s Heptares Therapeutics subsidiary to develop and commercialize Heptares’ lead candidate HTL0022562 a…
Read guide →New research from investigators at Cornell University not only uncovered how two highly lethal viruses have greater pathogenic potential when their proteins are combined but may have also stumbled upon potenti…
Read guide →